Picture of Alivus Life Sciences logo

ALIVUS — Alivus Life Sciences News Story

0.000.00%
in flag iconLast trade - 00:00
HealthcareBalancedMid CapHigh Flyer

Brief: India's Glenmark Life Sciences CEO Says Process Of Selling A Part Of Glenmark Pharmaceuticals Stake In Glenmark Lifesciences Is On

July 21 (Reuters) - Glenmark Life Sciences Ltd
 GLEM.NS :
    * PROCESS OF SELLING A PART OF GLENMARK PHARMACEUTICALS
STAKE IN
GLENMARK LIFESCIENCES IS ON
    * GLENMARK PHARMACEUTICALS IS RUNNING THE SALE PROCESS
    * WE’RE CONTRIBUTING TO THE SALE PROCESS, WHEREEVER REQUIRED
    * GLENMARK PHARMACEUTICALS IS RUNNING THE SALE PROCESS

Source text for Eikon:  ID: 
Further company coverage:  GLEM.NS 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Alivus Life Sciences

See all news